or Try an Advanced Search...

    Technical Analysis for OCEA - Ocean Biomedical, Inc.

    Grade Last Price % Change Price Change
    F 1.34 6.77% 0.09
    OCEA closed up 6.77 percent on Friday, April 26, 2024, on 3 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical OCEA trend table...
    Date Alert Name Type % Chg
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Wide Bands Range Expansion 6.77%
    Down 3 Days in a Row Weakness 6.77%
    Down 4 Days in a Row Weakness 6.77%
    Down 5 Days in a Row Weakness 6.77%
    Oversold Stochastic Weakness 6.77%
    NR7 Range Contraction -5.30%
    Older End-of-Day Signals for OCEA ...

       Recent Intraday Alerts

    Alert Time
    Possible Inside Day about 13 hours ago
    60 Minute Opening Range Breakout about 17 hours ago
    Up 10% about 17 hours ago
    Up 5% about 18 hours ago
    Up 3% about 18 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    OCEA Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Ocean Biomedical, Inc. is a Providence, Rhode Island-based biopharma company with an innovative business model that accelerates the development and commercialization of scientifically compelling assets from research universities and medical centers. Ocean Biomedical deploys the funding and expertise to move new therapeutic candidates efficiently from the laboratory to the clinic, to the world. Ocean Biomedical is currently developing five promising discoveries that have the potential to achieve life-changing outcomes in lung cancer, brain cancer, pulmonary fibrosis, and the prevention and treatment of malaria. The Ocean Biomedical team is working on solving some of the world’s toughest problems, for the people who need it most.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Lung Cancer Pulmonary Fibrosis Malaria Brain Cancer Treatment Of Malaria

    Is OCEA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 24 Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K
    Mar 28 13 Hot Stocks to Invest in According to Wall Street Analysts
    Mar 28 Ocean Biomedical (NASDAQ: OCEA) Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASL
    Mar 18 Ocean Biomedical: Shooting Upward, But Not Somewhere I Want To Be (Rating Upgrade)
    Mar 7 Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Feb 29 Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Feb 29 Ocean Biomedical (NASDAQ: OCEA) Announces Joint Venture Partner, Virion Therapeutics to Present Their First Clinical Study Data as an Accepted Late Breaker Presentation at 2024 APASL Global Liver Meeting
    Feb 28 Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Jan 17 Why DatChat Shares Are Trading Lower By Around 33%; Here Are 20 Stocks Moving Premarket
    Dec 5 EXCLUSIVE: Ocean Biomedical Announces Publication of Breast Cancer Research On New Tumor Suppression Pathway for Proprietary Antibody
    See more OCEA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 12.0301
    52 Week Low 0.52
    Average Volume 8,510,244
    200-Day Moving Average 2.47
    50-Day Moving Average 2.79
    20-Day Moving Average 2.15
    10-Day Moving Average 1.61
    Average True Range 0.35
    RSI (14) 29.08
    ADX 26.48
    +DI 15.71
    -DI 30.85
    Chandelier Exit (Long, 3 ATRs) 3.33
    Chandelier Exit (Short, 3 ATRs) 2.29
    Upper Bollinger Bands 3.43
    Lower Bollinger Band 0.88
    Percent B (%b) 0.18
    BandWidth 118.24
    MACD Line -0.49
    MACD Signal Line -0.39
    MACD Histogram -0.0972
    Fundamentals Value
    Market Cap 45.68 Million
    Num Shares 34.1 Million
    EPS -2.55
    Price-to-Earnings (P/E) Ratio -0.53
    Price-to-Sales 0.00
    Price-to-Book 100.67
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.59
    Resistance 3 (R3) 1.59 1.51 1.55
    Resistance 2 (R2) 1.51 1.45 1.51 1.53
    Resistance 1 (R1) 1.42 1.41 1.47 1.42 1.52
    Pivot Point 1.34 1.34 1.36 1.34 1.34
    Support 1 (S1) 1.26 1.28 1.30 1.26 1.16
    Support 2 (S2) 1.18 1.24 1.17 1.15
    Support 3 (S3) 1.09 1.18 1.13
    Support 4 (S4) 1.09